The preliminary public providing (IPO) of Dr Agarwal’s Well being Care subscribed 42 per cent on second day of bidding course of on Thursday, January 30, 2025. The general public difficulty acquired a bid for two,25,71,920 shares in opposition to 5,35,26,172 shares.
The Certified Institutional Consumers (QIBs) acquired 1.01 instances subscription, whereas Retail Particular person Buyers (RIIs) subscribed 23 per cent. In the meantime, the non-institutional buyers portion subscribed 12 per cent subscription.
Dr Agarwal’s Well being Care IPO: Day 1 subscription
On Day 1, the IPO noticed a subscription of seven per cent, with bids for 38,08,980 shares in opposition to 5,35,26,172 shares on supply. RIIs phase was subscribed 11 per cent, whereas NIIs class noticed a 6 per cent subscription.
Dr Agarwal’s Healthcare IPO: Allotment and itemizing dates
The allotment for the IPO is scheduled for Monday, February 3. Refunds will probably be processed on Tuesday, February 4, with shares credited to buyers’ Demat accounts on the identical day. The corporate’s shares are anticipated to be listed on the inventory exchanges on Wednesday, February 5.
Dr Agarwal’s Healthcare IPO: Allocation particulars
The IPO has allotted 50 per cent of the problem dimension for certified institutional patrons, 35 per cent for non-institutional buyers, and 15 per cent for retail buyers. A subscription element can also be out there for eligible staff.
Must you apply for Dr. Agarwal’s Well being Care IPO? Here is what market professional Anil Singhvi has to say
Zee Enterprise Managing Editor Anil Singhvi has really useful that solely high-risk buyers ought to think about subscribing to Dr Agarwal’s Well being Care IPO. He additionally highlighted the next key factors concerning the firm:
Positives:
– The promoters are skilled and professional- The corporate holds a robust model and a management place within the market- It operates on an asset-light enterprise model- The corporate has reputed anchor buyers backing it
Negatives:
– The enterprise has low entry barriers- The phase faces intense competition- Regardless of being established, the corporate’s enterprise development has solely accelerated recently- The contemporary difficulty portion is comparatively small in comparison with the Provide for Sale (OFS)- The corporate’s valuation seems costly when in comparison with trade friends
(With inputs from company)
